United States Peripheral Neuropathy Market Set for Transformative Growth with Rising Treatment Innovations 2025 | Top key players - GlaxoSmithKline, Abbott Laboratories, Cipla Laboratories.

Market Size and Growth:

The Peripheral Neuropathy Market size was valued US$ 1,539 million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031).

The Peripheral Neuropathy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Peripheral Neuropathy market report is an essential resource for market participants who are looking to gain a comprehensive understanding of the market and identify opportunities for growth.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/peripheral-neuropathy-market?sz

The Peripheral Neuropathy Market refers to the global industry focused on diagnosing, treating, and managing disorders that damage peripheral nerves, leading to pain, numbness, and weakness. It encompasses pharmaceuticals, medical devices, and therapeutic approaches. Market growth is driven by rising cases of diabetes, chemotherapy-induced neuropathy, and aging populations, boosting demand for effective treatments and advanced diagnostic solutions.

Recent Key Developments of United States (U.S):

Gene and Stem Cell Therapies: There is a significant focus and ongoing research in gene therapy, such as Helixmith's Engensis, and stem cell therapies for nerve regeneration. These aim to address the root cause of nerve damage rather than just managing symptoms, offering new hope for long-term relief. (June 2025, July 2025, August 2025)

Novel Drug Development: The market is seeing a rise in clinical trials and the development of novel small molecule pain modulators and targeted therapies. An example is a Phase 2b study of pilavapadin (LX9211) for diabetic peripheral neuropathic pain, which showed positive results. (March 2025, May 2025)

Non-Pharmacological and Device-Based Interventions: Non-invasive treatments like TENS therapy and LED red light therapy are gaining traction. These approaches, along with digital therapeutics and remote monitoring devices, are being integrated into personalized treatment plans to improve pain management and early detection of nerve damage. (June 2025)

Strategic Collaborations and Investments: Key players in the biopharmaceutical and medical technology sectors are forming strategic collaborations and making targeted investments to drive innovation. This includes efforts to develop new diagnostic tools and therapeutic agents. (August 2025)

FDA Guidance on CIPN: The FDA has released a draft guidance document for the clinical development of drugs and biological products to prevent and treat chemotherapy-induced peripheral neuropathy (CIPN). This indicates a concerted effort to address a major side effect of cancer treatment. (January 2025)

Key Players:

Averitas Pharma
Cipla Laboratories
Merck and Co
Bristol Meyer Squibb
Reddy's Lab
Elli Lilly and Company
Teva Pharmaceutical Industries
GlaxoSmithKline
Novartis AG
Abbott Laboratories.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=peripheral-neuropathy-market

Market Segmentation:

By Type: Diabetic Peripheral Neuropathy, Chemotherapy-induced Peripheral Neuropathy, Idiopathic Peripheral Neuropathy, Others.

By Treatment: Pharmacological Therapies, Non-Pharmacological Therapies, Others.

By End-User: Hospitals, Clinics, Ambulatory Centers, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/peripheral-neuropathy-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Peripheral Neuropathy market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Peripheral Neuropathy Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Peripheral Neuropathy market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Peripheral Neuropathy Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Peripheral Neuropathy Market in 2025?
◆ What is the projected growth rate of the Peripheral Neuropathy Market through 2033?
◆ Who are the key players in the Peripheral Neuropathy Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.